● At closeAs of Jul 2, 2026
Elekta AB (publ)
STO: EKTA-B✓$5.35SEK 51.70+1.87%
$1.96BMarket cap
-P/E ratio
1.03MVolume (24h)
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
 Eli Lilly and CompanyLLY | $1.14T | 42.53x | 15.63x | 34.89x | 0.54% |
 Johnson & JohnsonJNJ | $633.20B | 29.29x | 6.34x | 19.25x | 2.06% |
 AbbVie Inc.ABBV | $461.26B | 123.28x | 7.07x | 30.00x | 2.68% |
 UnitedHealth Group IncorporatedUNH | $386.29B | 31.34x | 0.84x | 18.59x | 2.15% |
| $338.51B |
| 20.57x |
| 4.31x |
| 12.91x |
| 2.94% |
 Merck & Co., Inc.MRK | $319.89B | 36.07x | 4.84x | 19.22x | 2.62% |
| Elekta AB (publ)STO: EKTA-B | $1.96B | - | - | - | - |
